Implications of “No Deal” Brexit for Orphan and Paediatric Medicines

Joseph Elborn, Mark Flear, Damian Downey

Research output: Other contribution


In the event of a “no deal” Brexit some of the UK’s most vulnerable, especially children with rare diseases, may lose access to the best medicine available, say Stuart Elborn, Mark Flear, and Damian Downey.
Original languageEnglish
TypeBlog entry
Media of outputBMJ Opinion blog
Publication statusPublished - 19 Jul 2019

Publication series

NameBMJ Blogs


Dive into the research topics of 'Implications of “No Deal” Brexit for Orphan and Paediatric Medicines'. Together they form a unique fingerprint.

Cite this